Forbes.com
12-13-2007, 12:00 PM
Forbes Investing Ideas
With drugs in the pipeline and cash in the bank, Myriad is on track to make a new run at old highs.
complete article here... ( http://www.forbes.com/finance/investingideas/2007/12/13/myriad-vivecon-biotechnology-pf-ii-in_jd_1212gurusow_inl.html?feed=rss_personalfinanc e_investingideas )
With drugs in the pipeline and cash in the bank, Myriad is on track to make a new run at old highs.
complete article here... ( http://www.forbes.com/finance/investingideas/2007/12/13/myriad-vivecon-biotechnology-pf-ii-in_jd_1212gurusow_inl.html?feed=rss_personalfinanc e_investingideas )